Is Abbott Laboratories (ABT) Expected to Post Impressive Earnings This Week?
We recently published a list of 10 Stocks Expected To Post Impressive Earnings This Week. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks expected to post impressive earnings this week.
Why Is Abbott Laboratories (ABT) Stock Surpassing 6.96% from Its 50-Day SMA?
Oppenheimer has recently initiated Abbott Laboratories (ABT) stock to Outperform rating, as announced on October 8, 2024, according to Finviz. Earlier, on September 19, 2024, Piper Sandler had initiated the stock to Overweight,
RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT)
In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Abbott Laboratories (ABT – Research Report),
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript
Welcome to Abbott's fourth quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by Abbott. With the exception of any participants' questions asked during the question-and-answer session,
Abbott Laboratories Reports Strong 2024 Financial Results
Abbott Laboratories ( ($ABT) ) has released its Q4 earnings. Here is a breakdown of the information Abbott Laboratories presented to its
Earnings call transcript: Abbott Labs Q3 2024 sees steady growth
Abbott Laboratories (NYSE:ABT) reported its Q3 2024 earnings, meeting EPS expectations while slightly missing revenue forecasts. The company posted an EPS of $1.34, aligning with analysts' predictions,
MarketBeat on MSN6h
Abbott Laboratories Will Outperform Healthcare Stocks in 2025
The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson ...
coinspeaker20h
Arcblock (ABT) Trading Volume Surges 2000% After Trump AI Endorsement
Arcblock (ABT) shot up by more than 45% in the past 24 hours and claimed a daily high of $1.92, facing resistance at $2.
bovnews2d
Abbott’s (ABT) Impressive Q4 and Bold Projections for 2025: What You Need to Know
The company’s projected adjusted diluted EPS for 2025 is between $5.05 and $5.25, marking double-digit growth at the midpoint. Abbott’s first-quarter 2025 adjusted EPS is expected to be between $1.05 ...
Abbott Laboratories: Now Back In The Buy Zone (Rating Upgrade)
Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month.
Abbott Laboratories: Strong Performance and Promising Outlook Support Buy Rating
Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to ...
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall
Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong ...
MassDevice2d
Abbott sales come up just shy of Q4 expectations on Wall Street, highlights EP growth
Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright ...
Abbott Q4 Earnings Meet, Margins Down, Stock Falls in Pre-Market
Abbott Laboratories ABT reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.34, in line with the Zacks ...
Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Arrowhead Pharmaceuticals (ARWR)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT – Research Report), ...
NIA court convicts 2 for Links with Al Qaeda-affiliated module in Assam
Special Court in Guwahati has convicted two individuals in connection with their involvement in the Ansarullah Bangla Team ...
Gov. Abbott calls on Congress to pay back Texas for $11.1B spent on border
Gov. Abbott sent letters on Thursday to U.S. Congressional leaders requesting the federal government reimburse Texas $11.1 billion for border budget.